Redeye: Sdiptech - Continued operational momentum
While Sdiptech continues to deliver solid reports in line with our expectations, the significant discount (35-45%) to peers remain intact. As we have argued earlier, we believe that the discount should decrease gradually as Sdiptech continues to acquire while organic growth and margins are stable. Our Base case of SEK 51, excluding future acquisitions, implies a potential of 30% relative to the current share price.
Read more and download the research update: http://bit.ly/2VwLaa3
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/